Valuation: Virbac

Market Cap 2.64B 3.05B 2.49B 2.26B 4.24B 292B 4.27B 29.78B 11.51B 148B 11.44B 11.19B 472B P/E 2026 *
15.4x
P/E 2027 * 13.9x
Enterprise Value 2.76B 3.19B 2.61B 2.37B 4.44B 306B 4.47B 31.18B 12.05B 155B 11.98B 11.71B 495B EV / Sales 2026 *
1.78x
EV / Sales 2027 * 1.65x
Free-Float
49.03%
Yield 2026 *
0.55%
Yield 2027 * 0.65%
1 day-0.95%
1 week+1.30%
Current month-3.26%
1 month-5.17%
3 months-7.42%
6 months-5.02%
Current year-12.73%
1 week 301
Extreme 301
318.5
1 month 301
Extreme 301
334
Current year 301
Extreme 301
389.5
1 year 301
Extreme 301
389.5
3 years 239
Extreme 239
400
5 years 215
Extreme 215
448.5
10 years 102.1
Extreme 102.1
448.5
Manager TitleAgeSince
Chief Executive Officer 46 2025-08-31
Chief Executive Officer 50 2024-09-26
Chief Operating Officer 64 2021-12-31
Director TitleAgeSince
Chairman 61 2006-03-31
Director/Board Member 68 2010-07-27
Director/Board Member 65 2017-09-04
Date Insider Type Main position Quantity % Market Cap. Importance
4/22/24 Sell

Chief Executive Officer

810 0.0096%
4/22/24 Sell

Chief Executive Officer

140 0.0017%
4/22/24 Sell

Chief Executive Officer

1,688 0.0200%
Change 5-day change 1-year change 3-year change Capi.($)
-0.95%+1.30%-0.48%+21.17% 3.05B
-0.26%-0.49%-50.53%-59.39% 30.34B
-1.20%-3.55%+21.93%+92.50% 11.49B
+0.36%-5.56%-13.95%0.00% 3.81B
-0.68%-6.52%+31.63%+22.60% 1.9B
+0.58%+0.58%+12.32%+45.78% 1.86B
-0.04%-5.08%-10.46%+178.33% 1.42B
-0.12%-5.02%-21.70%-6.67% 1.17B
-0.39%+13.83%-5.49%-6.31% 1.02B
-0.89%-7.64%-11.33%-43.45% 1.02B
Average -0.36%-1.27%-4.81%+24.45% 5.71B
Weighted average by Cap. -0.43%-1.38%-22.96%-6.16%

Financials

2026 *2027 *
Net sales 1.55B 1.79B 1.46B 1.33B 2.49B 171B 2.51B 17.48B 6.75B 86.98B 6.72B 6.57B 277B 1.65B 1.9B 1.56B 1.41B 2.65B 182B 2.66B 18.57B 7.17B 92.39B 7.13B 6.97B 294B
Net income 171M 197M 162M 147M 275M 18.94B 277M 1.93B 746M 9.61B 742M 725M 30.62B 190M 219M 179M 163M 305M 20.99B 307M 2.14B 827M 10.65B 822M 804M 33.94B
Net Debt 124M 144M 118M 107M 200M 13.77B 201M 1.4B 542M 6.98B 539M 527M 22.26B 68.29M 78.8M 64.55M 58.6M 110M 7.56B 110M 771M 298M 3.83B 296M 289M 12.22B
Logo Virbac
Virbac specializes in the research, production and marketing of veterinary medicines. Net sales break down by family of products as follows: - pet medications (60.7%): pest control drugs, vaccines, antibiotics, anesthetics, anti-inflammatory drugs, mouth/dental care products, ophthalmologic and dermatological products intended for dogs, cats, horses, birds, rodents, etc. The group also offers foods and electronic identification chips; - livestock medications (39.3%): pest control drugs and antibiotics intended for cattle, sheep, pigs, poultry, etc. Net sales are distributed geographically as follows: Europe (41.6%), Latin America (15.2%), North America (13.6%), India/Africa/Middle East (12.2%), Eastern Asia (10.5%) and Pacific (6.9%).
Employees
6,442
Date Price Change Volume
26-09-16 312.00 -0.95% 2,763
26-09-15 €315.00 +0.16% 9,435
26-09-14 €314.50 +0.96% 7,414
26-09-11 €311.50 +3.15% 11,829
26-09-10 €302.00 -1.95% 4,268
Trader
Investor
Global
Quality
ESG MSCI
AA
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
8
Last Close Price
315.00EUR
Average target price
411.88EUR
Spread / Average Target
+30.75%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. VIRP Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!